Sanofi Sarclisa accepted for USFDA priority review for transplant-ineligible newly diagnosed multiple myeloma Ruchika Sharma27 May 2024 11:30 AM ISTParis: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License...
Sanofi, Formation Bio, OpenAI collaborate to build AI-powered software to accelerate drug development Ruchika Sharma21 May 2024 9:30 AM ISTParis: Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to...
Submit preliminary analysis of primary data of subjects above 18 years in India: CDSCO Panel Tells Sanofi on Amlitelimab study Dr. Divya Colin19 May 2024 6:00 PM ISTNew Delhi: After considering the phase III clinical study protocol of the monoclonal antibody Amlitelimab in the treatment of moderate-to-severe...
Sanofi, Novavax ink pact to co-commercialize COVID vaccine, develop novel flu-COVID combination vaccines Ruchika Sharma12 May 2024 10:00 AM ISTParis: Sanofi has entered into a co-exclusive licensing agreement with Novavax, a biotechnology company headquartered in Maryland, US to develop...
USFDA approves Gland Pharma Plerixafor Injection Ruchika Sharma7 May 2024 1:30 PM ISTHyderabad: Generic injectable-focused pharmaceutical company, Gland Pharma Limited, has received approval from the United States Food and Drug...
Nirsevimab use may reduce infant hospitalizations due to RSV by 82 percent: Lancet Dr. Kamal Kant Kohli3 May 2024 7:00 PM ISTNirsevimab use may reduce infant hospitalizations due to respiratory syncytial virus (RSV) by 82 percent, shows real world evidence published in The...
Submit post-marketing safety data of Belumosudil in Chronic graft versus host disease: CDSCO Panel Tells Sanofi Dr. Divya Colin21 April 2024 6:00 PM ISTNew Delhi: Responding to the proposal presented by the drug major Sanofi to import and market Belumosudil tablets 200 mg, the Subject Expert Committee...
Innate Pharma announces advancement of Sanofi-developed NK Cell Engager SAR443579/ IPH6101 progressing to Phase 2 for blood cancer patients Ruchika Sharma15 April 2024 3:17 PM ISTFrance: Innate Pharma SA has announced that the first patient was dosed in the Phase 2 dose expansion part of the Sanofi-sponsored clinical trial...
Sanofi new polio vaccine gets nod in India Ruchika Sharma6 April 2024 3:00 PM ISTNew Delhi: Drug giant Sanofi has received a nod for an alternative injectable vaccine, IMOVAX-Polio, to replace the widely used Inactivated Polio...
AstraZeneca-Sanofi Beyfortus approved in Japan for prevention of RSV disease in infants Ruchika Sharma31 March 2024 12:30 PM ISTCambridge: AstraZeneca and Sanofi's Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in Japan for the prophylaxis of...
Dr Reddy's Labs to promote, distribute Sanofi paediatric, adult vaccine brands in India Ruchika Sharma29 March 2024 2:25 PM ISTThese brands saw combined sales of approx. Rs 426 crores as per IQVIA MAT February 2024.
Sanofi Gets CDSCO Panel Nod To Import, Market Nirsevimab to Treat Respiratory Syncytial Virus Disease Dr. Divya Colin27 March 2024 6:00 PM ISTNew Delhi: Pharmaceutical major Sanofi Healthcare India has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
